Sign in

CIK 0001498382

  • Non-accelerated filer
  • Smaller reporting company

TuHURA Biosciences, Inc./NV

Sign in to watch
Ticker
HURA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
990360497
Phone
+1 813-875-6600
Business address
10500 UNIVERSITY CENTER DR., SUITE 110, TAMPA, FL, 33612
Former names
Kintara Therapeutics, Inc., DelMar Pharmaceuticals, Inc., Berry Only Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-01-06 Dearborn Dan Chief Financial Officer Grant or award · Options (Right to Buy) +273,696 273,696
2025-12-12 Dearborn Dan Chief Financial Officer Grant or award · Options (Right to Buy) +1,531,367 1,531,367
2024-11-12 Dearborn Dan Chief Financial Officer Grant or award · Options (Right to Buy) +489,848 489,848
2024-10-18 Dearborn Dan Chief Financial Officer Grant or award · Options (Right to Buy) +33,991 33,991
2024-10-18 Dearborn Dan Chief Financial Officer Grant or award · Options (Right to Buy) +68,438 68,438
2024-10-18 Dearborn Dan Chief Financial Officer Grant or award · Options (Right to Buy) +232,570 232,570
2024-10-18 Dearborn Dan Chief Financial Officer Grant or award · Options (Right to Buy) +15,744 15,744
2024-10-18 Dearborn Dan Chief Financial Officer Grant or award · Options (Right to Buy) +66,658 66,658

Page 1 of 1 · 8 trades